Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oral therapy for CML developed at Novartis approved by FDA

May 14, 2001

New antimitotic anticancer agents related to halichondrin synthesized and tested at Eisai

May 11, 2001

Idec prepares responses to FDA complete review letter for Zevalin

May 11, 2001

Polish scientists report on antiangiogenic effects of genistein in animal tumor models

May 11, 2001

LEP continues in active development for oncology indications

May 11, 2001

Structurally novel class of antiangiogenic agents discussed at Trends in Drug Research meeting

May 11, 2001

Xenerex and Eos enter antibody research alliance

May 11, 2001

Mechanism of anticancer action of NB-1011 investigated

May 11, 2001

Etoposide and paclitaxel conjugates prepared by Nobex for improving drug delivery

May 10, 2001

AstraZeneca completes patient enrollment in NSCLC phase III trials of Iressa

May 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Shanghai Yingli Pharmaceutical identifies new KRAS mutant inhibitors
BioWorld Science
Shanghai Yingli Pharmaceutical Co. Ltd. has discovered hydrazine-structured compounds as inhibitors of GTPase KRAS and its mutants. They are reported to be useful...